Political News, Analysis and Opinion
The Real News Network
Fed’s Powell: No economic recovery until coronavirus is contained FOX Business’ Edward Lawrence breaks down what Fed Chairman Jerome Powell will address on Capital Hill concerning coronavirus recovery. At the … Read More
Following four consecutive months of contraction, the Federal Reserve Bank of New York released a report on Wednesday showing New York manufacturing activity expanded in the month of July. The … Read More
How to prepare for potential Biden tax hikes CPA and business analyst Dan Geltrude gives advice for potential tax increases. After a three-month delay, tax time for Americans is finally … Read More
How to prepare for potential Biden tax hikes CPA and business analyst Dan Geltrude gives advice for potential tax increases. In 2018, the average tax refund was a whopping $2,881. Continue Reading … Read More
Small business becomes top hand sanitizer brand overnight Soapbox Soaps CEO and co-founder David Simnick and Soapbox Soaps President and COO Daniel Doll discuss becoming a leader in the hand … Read More
White House pushing stimulus to drive down unemployment, boost reelection chances: Gasparino Sources tell FOX Business’ Charlie Gasparino the White House is pushing Republicans to pass a stimulus bill, compromising … Read More
Owners of diner destroyed in riots: Minneapolis is still our home Town Talk Diner and Gastropub owners Kacey White and Charles Stotts discuss their future plans after their business was … Read More
New rules for foreign students provides more flexibility: DHS Secretary Chad Wolf Acting Secretary of Homeland Security Chad Wolf on ICE’s new guidelines for foreign students. The Trump administration said … Read More
Biogen has asked the feds to let it market a potentially groundbreaking treatment for Alzheimer’s disease in the US, the company said Wednesday. The Massachusetts-based biotech firm asked the Food … Read More
Today’s Daily Dose brings you news about the pipeline progress of Annovis Bio, new entrants in the COVID-19 drug development space, Livongo Health’s upbeat preliminary Q2 revenue, Regeneron’s BARDA contract, … Read More
